TALVEY: payments to doctors
Payments that named TALVEY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 9,636
- Transactions
- 28,328
- Average per transaction
- $68
The per-transaction average — $68 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,636 providers the average total is $201, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $1,653,729 | 85.4% |
| Janssen Global Services, LLC | $151,595 | 7.8% |
| Janssen Scientific Affairs, LLC | $129,979 | 6.7% |
| Janssen Research & Development, LLC | $438 | 0.0% |